Impact of rheumatoid arthritis in Turkey: A questionnaire study

Simple item page
dc.contributor.authorDireskeneli H.
dc.contributor.authorAkkoç N.
dc.contributor.authorBes C.
dc.contributor.authorÇakir N.
dc.contributor.authorÇefle A.
dc.contributor.authorÇobankara V.
dc.contributor.authorDalkiliç E.
dc.contributor.authorDinç A.
dc.contributor.authorErtenli I.
dc.contributor.authorGül A.
dc.contributor.authorHamuryudan V.
dc.contributor.authorInanç M.
dc.contributor.authorKalyoncu U.
dc.contributor.authorKaraaslan Y.
dc.contributor.authorKaşifoǧlu T.
dc.contributor.authorKeser G.
dc.contributor.authorKeskin G.
dc.contributor.authorKisacik B.
dc.contributor.authorKiraz S.
dc.contributor.authorMasatlioǧlu S.
dc.contributor.authorOnat A.M.
dc.contributor.authorÖzbek S.
dc.contributor.authorÖztürk M.A.
dc.contributor.authorPamuk Ö.N.
dc.contributor.authorPay P.
dc.contributor.authorPirildar T.
dc.contributor.authorSayarlioǧlu M.
dc.contributor.authorŞenel S.
dc.contributor.authorŞentürk T.
dc.contributor.authorTaşan D.
dc.contributor.authorTerzioǧlu E.
dc.contributor.authorYazici A.
dc.contributor.authorYücel E.
dc.date.accessioned2024-07-22T08:17:05Z
dc.date.available2024-07-22T08:17:05Z
dc.date.issued2014
dc.description.abstractObjective: Unmet needs of rheumatoid arthritis (RA) patients regarding physician/patient communication, treatment preferences and quality of life issues were investigated in a Turkish survey study. Methods: The study was conducted with the contribution of 33 rheumatologists, and included 519 RA patients. The study population included patients who had been on biologic therapy for >6 months and were still receiving biologic therapy (BT group), and those who were biologic naive, but found eligible for biologic treatment (NBT group). Of the RA patients, 35.5% initially had a visit to an internal disease specialist, 25.5% to a physical therapy and rehabilitation specialist, and 12.2% to a rheumatology specialist for their RA complaints. The diagnosis of RA was made by a rheumatologist in 48.2% of patients. Results: The majority of RA patients (86.3%) visit their doctor within 15-week intervals. Most of the physician-patient communication focused on disease symptoms (99.0%) and impact of the disease on quality of life (61.8%). The proportion of RA patients who perceived their health status as good/very good/excellent was higher in the BT group than in the NBT group (74.3% vs. 51.5%, p<0.001). However, of those RA patients in the NBT group, only 24.8% have been recommended to start a biologic treatment by their doctors. With respect to dose frequency options, once-monthly injections were preferred (80%) to a bi-weekly injection schedule (8%). Conclusion: In conclusion, RA patients receiving biologic therapy reported higher rates of improved symptoms and better quality of life and seemed to be more satisfied with their treatment in our study. © Clinical and Experimental Rheumatology 2014.
dc.identifier.issn0392856X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16964
dc.language.isoEnglish
dc.publisherClinical and Experimental Rheumatology S.A.S.
dc.subjectAdult
dc.subjectAntirheumatic Agents
dc.subjectArthritis, Rheumatoid
dc.subjectAttitude of Health Personnel
dc.subjectBiological Products
dc.subjectCommunication
dc.subjectDrug Administration Schedule
dc.subjectFemale
dc.subjectHealth Care Surveys
dc.subjectHealth Knowledge, Attitudes, Practice
dc.subjectHealth Services Needs and Demand
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeeds Assessment
dc.subjectPatient Preference
dc.subjectPatient Satisfaction
dc.subjectPatients
dc.subjectPerception
dc.subjectPhysician-Patient Relations
dc.subjectQuality of Life
dc.subjectQuestionnaires
dc.subjectSeverity of Illness Index
dc.subjectTime Factors
dc.subjectTreatment Outcome
dc.subjectTurkey
dc.subjectadalimumab
dc.subjectcorticosteroid
dc.subjectetanercept
dc.subjectinfliximab
dc.subjectleflunomide
dc.subjectmethotrexate
dc.subjectnonsteroid antiinflammatory agent
dc.subjectacupuncture
dc.subjectadult
dc.subjectalternative medicine
dc.subjectarticle
dc.subjectbiological therapy
dc.subjectcommunication skill
dc.subjectcontrolled study
dc.subjectDAS28
dc.subjectdoctor patient relation
dc.subjectfemale
dc.subjecthealth status
dc.subjecthealth survey
dc.subjecthuman
dc.subjecthuman impact (environment)
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmedical specialist
dc.subjectpatient preference
dc.subjectphysiotherapy
dc.subjectpriority journal
dc.subjectquality of life
dc.subjectquestionnaire
dc.subjectrehabilitation
dc.subjectrheumatoid arthritis
dc.subjectrheumatology
dc.subjectTurkey (republic)
dc.titleImpact of rheumatoid arthritis in Turkey: A questionnaire study
dc.typeArticle

Files

Collections

Scopus Koleksiyonu